Get the app!
Back to Trades

Fenimore Christopher R.

EVP Finance CFOCIK 0001697422

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
3
Buy transactions
0
Sell transactions
0
Companies
1
Active
2025–2026

Across 3 filings between 2025–2026, Fenimore Christopher R., EVP Finance CFO, has disclosed $28.7M in transactions — all concentrated in REGENERON PHARMACEUTICALS, INC. (REGN). Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

3 loaded
Nov 4REGN
REGENERON PHARMACEUTICALS, INC.
Fenimore Christopher R.EVP Finance CFOGift$8.6M
Aug 20REGN
REGENERON PHARMACEUTICALS, INC.
Fenimore Christopher R.EVP Finance CFOExercise$8.5M
Dec 9REGN
REGENERON PHARMACEUTICALS, INC.
Fenimore Christopher R.EVP Finance CFOGrant$11.6M

3 filings